头颈部腺样囊性癌碳离子放疗的预后因素:组织学亚型的影响
本研究纳入100例接受碳离子放疗的头颈部腺样囊性癌患者,总剂量57.6或64.0 Gy(RBE),16次分割。中位随访60个月,5年局部控制率68.6%、总生存率74.8%、无远处转移生存率65.7%。实性生长模式是总生存和无远处转移生存的独立危险因素,但局部控制无显著差异。
要点
- 实性生长模式是OS(p=0.033)和DMFS(p=0.024)的独立危险因素。
- 处方剂量(p=0.001)和肿瘤大体体积(p=0.002)是局部控制的独立危险因素。
- 实性/非实性生长模式的局部控制无显著差异(p=0.093)。
核心结论
- 碳离子放疗似能局部控制头颈部实性生长模式腺样囊性癌。
- 需改进干预以延长无远处转移生存和总生存。
研究设计与样本
- 回顾性研究纳入100例经碳离子放疗、组织学亚型明确的头颈部腺样囊性癌患者。
- 碳离子放疗总剂量57.6或64.0 Gy(RBE),16次分割。
- 组织学分级依据实性生长模式的存在与否定义。
主要发现
- 中位随访60个月,5年局部控制率68.6%、总生存率74.8%、无远处转移生存率65.7%。
- 多因素分析显示处方剂量(p=0.001)和肿瘤大体体积(p=0.002)是局部控制的独立危险因素。
- 实性生长模式是总生存(p=0.033)和无远处转移生存(p=0.024)的独立危险因素。
- 实性/非实性生长模式的局部控制无显著差异(p=0.093)。
临床怎么用
- 对头颈部腺样囊性癌实性生长模式患者,碳离子放疗可考虑用于局部控制。
- 需关注实性生长模式患者的远处转移和总生存,加强干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The aim of this study was to evaluate the effect of histological subtypes of head and neck adenoid cystic carcinoma (ACC) on the results of carbon-ion radiotherapy (CIRT). MATERIAL AND METHODS: Of the 113 patients with ACC who were treated with CIRT between December 2006 and July 2013, 100 patients with identified histological subtypes were enrolled in this study. CIRT at a total dose of 57.6 or 64.0Gy (RBE) was administered in 16 fractions. Histological grading was defined as the presence or absence of a solid growth pattern. RESULTS: Median follow-up was 60 months. 5-Year local control (LC), overall survival (OS) and distant metastasis free survival (DMFS) of all patients were 68.6%, 74.8% and 65.7%, respectively. On multivariate analysis, the prescribed dose (p=0.001) and gross tumor volume (p=0.002) were significant independent risk factors for LC. No significant difference for local control of solid/non-solid growth patterns was found (p=0.093). Solid growth pattern was an independent risk factor for both OS (p=0.033) and DMFS (p=0.024). CONCLUSIONS: CIRT appears able to locally control solid growth pattern ACC in the head and neck. Improved intervention is needed to extend DMFS and OS.
引用
- Ikawa H, Koto M, Takagi R, et al. Prognostic factors of adenoid cystic carcinoma of the head and neck in carbon-ion radiotherapy: The impact of histological subtypes. Radiother Oncol. 2017. PMID: 28528680. doi:10.1016/j.radonc.2017.04.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。